MedPath

Interactions between 3,4-methylenedioxymethamphetamine (MDMA or ’ecstasy’) and Ä9-tetrahydrocannabinol (THC or ‘marihuana’) in humans

Completed
Conditions
MDMA and THC (co-) exposure
Registration Number
NL-OMON27417
Lead Sponsor
ZonMw
Brief Summary

/A

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
16
Inclusion Criteria

1. Subjects must be at least 18 but not older than 40 years of age.

2. Subjects must have used ecstasy on at least 8 separate occasions during the past two years.

Exclusion Criteria

1. History of prescribed medication within the month prior to the start of treatment with trial medication with the exception of oral contraceptives;

2. History of OTC medication within 1 months prior to the start of treatment with trial medication with exception of occasional use of paracetamol;

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath